Skip to main content Accessibility help

Molecular and Descriptive Epidemiology of Multidrug-Resistant Enterobacteriaceae in Hospitalized Infants

  • Brian Anderson (a1), Sarah Nicholas (a1), Bruce Sprague (a2), Joseph Campos (a1) (a3) (a4) (a5) (a6), Billie Short (a1) (a7) (a4) and Nalini Singh (a1) (a8) (a9) (a4)...



To investigate the epidemiology of multidrug-resistant Enterobacteriaceae (MDRE) in hospitalized infants.


From 2000 through 2005, active surveillance cultures for MDRE were performed for patients admitted to a 40-bed neonatal intensive care unit (NICU) that provides care for critically ill infants 6 months of age or younger. MDRE epidemiology and the genetic relatedness of MDRE strains determined by repetitive-sequence polymerase chain reaction were analyzed.


Active surveillance cultures revealed that 759 (23%) of 3,370 NICU infants (or approximately 1 in 5) developed MDRE colonization or infection and that 613 (72%) of the 853 isolates with epidemiologic data available were healthcare acquired. MDRE colonization occurred more frequently (in 653 infants [86%]) than did MDRE infection (in 106 [14%]). Of the 653 infants with MDRE colonization, 119 (18%) eventually became infected, with 29 (4%) acquiring sterile site infections. The most commonly isolated organisms were the Enterobacter species, accounting for 612 (71%) of the 862 isolates. Molecular epidemiologic analysis revealed that genetic-relatedness clustering (related clusters defined as having a genetic similarity coefficient greater than 95%) varied depending on microbial species. Clustering was detected for 36 (78%) of the 46 Enterobacter aerogenes isolates, 22 (45%) of the 49 Enterobacter cloacae isolates, and 13 (59%) of the 22 Klebsiella pneumoniae isolates.


Hospitalized infants are at significant risk of acquiring MDRE, specifically Enterobacter species, at the study institution. Active surveillance cultures identified colonized patients who likely contributed to the institutional reservoir of MDRE. Molecular epidemiologic studies suggest that both patient-to-patient transmission and de novo acquisition of resistance play a role in the acquisition of these organisms, and that the clinical significance of such acquisition varies by species. The high percentage of E. aerogenes isolates that demonstrated genetic clustering suggests that monitoring the prevalence of this organism could serve as a useful measure of compliance with infection control procedures.


Corresponding author

Division of Infectious Disease, Children's National Medical Center, 111 Michigan Ave., NW, Washington, DC 20010 (


Hide All
1.Almuneef, MA. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis 2001;32:220227.
2.Singh, N, Patel, KM, Léger, MM, et al.Risk of resistant infections with Enterobacteriaceae in hospitalized neonates. Pediatr Infect Dis J 2002;21:10291033.
3.Toltzis, P. Molecular epidemiology of antibiotic-resistant gram-negative bacilli in a neonatal intensive care unit during a nonoutbreak period. Pediatrics 2001;108:11431148.
4.Bradford, PA. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001;14:933951.
5.Hanberger, H, Erlandsson, M, Burman, LG, et al; ICU-STRAMA Study Group. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs: report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis 2004;36:2430.
6.Jacoby, GA. Mechanisms of disease: the new β-lactamases. N Engl J Med 2005;352:380391.
7.Couto, RC, Pedrosa, TM, Tofani Cde, P, Pedroso, ER. Risk factors for nosocomial infection in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2006;27:571575.
8.Pfaller, MA, Segreti, J. Overview of the epidemiological profile and laboratory detection of extended-spectrum β-lactamases. Clin Infect Dis 2006;42(suppl 4):S153S163.
9.Rupp, ME, Fey, PD. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003;63:353365.
10.Kanafani, ZA, Mehio-Sibai, A, Araj, GF, Kanaan, M, Kanj, SS. Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 2005;33:326332.
11.Wu, TL, Chia, JH, Su, LH, Kuo, AJ, Chu, C, Chiu, CH. Dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae in pediatric intensive care units. J Clin Microbiol 2003;41:48364838.
12.Harris, AD, McGregor, JC, Furuno, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis 2006;43(suppl 2):S57S61.
13.Briggs, S, Ussher, J, Taylor, S. Extended-spectrum beta-lactamase-producing Enterobacteriaceae at Middlemore Hospital. N Z Med J 2005;118:U1563.
14.Cosgrove, SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006;42(suppl 2):S82S89.
15.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 17th informational supplement. CLSI document. Wayne, PA: CLSI, 2007: M100-S17.
16.Jarlier, V, Nicolas, MH, Fournier, G, Philippon, A. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867878.
17.Healy, M. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol 2005;43:199207.
18.Saeed, S, Fakih, MG, Riederer, K, Shah, AR, Khatib, R. Interinstitutional and intrainstitutional transmission of a strain of Acinetobacter baumannii detected by molecular analysis: comparison of pulsed-field gel electrophoresis and repetitive sequence-based polymerase chain reaction. Infect Control Hasp Epidemiol 2006;27:981983.
19.Bou, G, Cerveró, G, Dominguez, MA, Quereda, C, Martinez-Beltran, J. PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and meropenem-resistant Acinetobacter baumannii. Clin Microbiol Infect 2000;6:635643.
20.Apisarnthanarak, A, Mundy, LM. Prevalence, treatment, and outcome of infection due to extended-spectrum β-lactamase–producing microorganisms. Infect Control Hosp Epidemiol 2006;27:326327.
21.Calil, R. Reduction in colonization and nosocomial infection by multi-resistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 2001;29:133138.
22.Donskey, CJ. Antibiotic regimens and intestinal colonization with antibiotic-resistant gram-negative bacilli. Clin Infect Dis 2006;43(suppl 2):S62S69.
23.Thomson, KS, Moland, ES. Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase–producing Enterobacteriaceae. Antimicrob Agents Chemother 2001;45:35483554.
24.Saladin, M, Cao, VT, Lambert, T, et al.Diversity of CTX-M beta-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol Lett 2002;209:161168.
25.Sandiumenge, A, Diaz, E, Rodriguez, A, et al.Impact of diversity of antibiotic use on the development of antimicrobial resistance. J Antimicrob Chemother 2006;57:11971204.
26.Takesue, Y, Ohge, H, Sakashita, M, et al.Effect of antibiotic heterogeneity on the development of infections with antibiotic-resistant gram-negative organisms in a non-intensive care unit surgical ward. World J Surg 2006;30:12691276.
27.Ibrahim, EH, Ward, S, Sherman, G, Kollef, MH. A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. Chest 2000;117:14341442.
28.Benson, L, Sprague, B, Campos, J, Singh, N. Epidemiology of infection and colonization with vancomycin-resistant enterococci and frequency of cocolonization with methicillin-resistant Staphylococcus aureus in children. Infect Control Hosp Epidemiol 2007;28:880882.
29.Sherer, CR, Sprague, BM, Campos, JM, et al.Characterizing vancomycin-resistant enterococci in neonatal intensive care. Emerg Infect Dis 2005;11:14701472.

Related content

Powered by UNSILO

Molecular and Descriptive Epidemiology of Multidrug-Resistant Enterobacteriaceae in Hospitalized Infants

  • Brian Anderson (a1), Sarah Nicholas (a1), Bruce Sprague (a2), Joseph Campos (a1) (a3) (a4) (a5) (a6), Billie Short (a1) (a7) (a4) and Nalini Singh (a1) (a8) (a9) (a4)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.